Data publsihed in the Archives of Ophthalmology show that rosiglitazone has been found to delay the onset of Proliferative Diabetic Retinopathy
Filed under: Nuclear Receptor | Tagged: Avandia, glaxosmithkline, GSK, Rosiglitazone, Venvia
Name (required)
E-mail (will not be published) (required)
Website
Notify me of follow-up comments via email.
